3PBIOVIAN Contributes to Advancing Personalized Cancer Immunotherapies Through the PITÁGORAS Project
3PBIOVIAN reinforces its commitment to continuous learning through UPNA micro-credentials
3PBIOVIAN expands its mammalian capacity with a second 2,000 L bioreactor
